WNT3
protein-codingWnt family member 3, the group of Wnt family
Gene summary
The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during embryogenesis. This gene is a member of the WNT gene family. It encodes a protein which shows 98% amino acid identity to mouse Wnt3 protein, and 84% to human WNT3A protein, another WNT gene product. The mouse studies show the requirement of Wnt3 in primary axis formation in the mouse. Studies of the gene expression suggest that this gene may play a key role in some cases of human breast, rectal, lung, and gastric cancer through activation of the WNT-beta-catenin-TCF signaling pathway. This gene is clustered with WNT15, another family member, in the chromosome 17q21 region. [provided by RefSeq, Jul 2008]
- INT4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~70.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0060764
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0010110
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0060764
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0060764
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0060764
Submitter: ClinGen
The *WNT3* gene is located on chromosome 17 at 17q32.32 and encodes Wnt family member 3 (*WNT3*), a signalling protein within the Wnt/b-catenin signalling pathways. *WNT3* was first reported in relation to autosomal recessive tetra-amelia syndrome 1 in 2004 (PMID: 14872406). Tetra-amelia syndrome is characterized by the complete absence of all four limbs with additional multisystem malformations. Evidence supporting this gene-disease relationship includes case-level data and experimental evidence. To date, the disorder has been reported in a single consanguineous family of Aramaic descent. The disorder was diagnosed prenatally in four affected fetuses which were terminated between weeks 13 and 20 of gestation. Positional cloning identified a homozygous stop-gain variant c.247C>T p.(Gln83Ter) in the affected fetuses. The mechanism of pathogenicity is presumed to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (expression and mouse model evidence). The gene disease association is supported by a spatial and temporal expression pattern in the developing mouse embryo which is consistent with the clinical phenotype (PMID: 12569130). Both targeted and conditional knockout mouse models support a crucial role for *WNT3* during embryogenesis and limb formation, recapitulating aspects of the phenotype spectrum associated with tetra-amelia syndrome 1 (PMID: 12569130, 10431240). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Syndromic disorders GCEP on the meeting date 16th May 2025 (SOP Version 11).
Inheritance Pattern: Unknown
Disease ID:MONDO:0060764
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Gastrointestinal; Genitourinary; Musculoskeletal; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to WNT3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_030753.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 48 | 1 | 51 | ||
| missense | 1 | 50 | 51 | |||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 1 | 52 | 48 | 1 | 103 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_110380.1 | 4 | MANE Select | |
| Ensembl | ENSP00000225512.5 | 4 | MANE Select | |
| Ensembl | ENSP00000516407.1 | 2 | Standard | |
| Ensembl | ENSP00000516408.1 | 2 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| wnt3 | Danio rerio | Structure: cloaca Quality: increased width abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Gastric cancer - Homo sapiens (human)
- mTOR signaling pathway - Homo sapiens (human)
- Cushing,s syndrome - Homo sapiens (human)
- Breast cancer - Homo sapiens (human)
- HTLV-I infection - Homo sapiens (human)
Biological Process
- cell morphogenesis
- mesoderm formation
- gamete generation
- axon guidance
- anterior/posterior axis specification
Molecular Function
- frizzled binding
- protein binding
- protein domain specific binding
- receptor ligand activity
Cellular Component
- extracellular region
- extracellular space
- endoplasmic reticulum lumen
- Golgi lumen
- plasma membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000225512
- Coding exons
- 4
- Length
- 70649
- Individuals with no LoFs
- 122322
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 122323
- p
- 0.00000409
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.18 | 109 | 251 | 0.435 | 0.0000184 | 2313 |
| Missense (PolyPhen) | 30 | 99.567 | 0.3013 | 918 | ||
| Synonymous | 0.595 | 106 | 114 | 0.929 | 0.00000937 | 706 |
| Loss of Function | 3.19 | 2 | 15.6 | 0.128 | 7.59e-7 | 157 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00020 | 0.00010 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Ligand for members of the frizzled family of seven transmembrane receptors (Probable). Functions in the canonical Wnt signaling pathway that results in activation of transcription factors of the TCF/LEF family (PubMed:26902720). Required for normal gastrulation, formation of the primitive streak, and for the formation of the mesoderm during early embryogenesis. Required for normal formation of the apical ectodermal ridge (By similarity). Required for normal embryonic development, and especially for limb development (PubMed:14872406). {ECO:0000250|UniProtKB:P17553, ECO:0000269|PubMed:14872406, ECO:0000269|PubMed:26902720, ECO:0000305}.;
- Disease
- DISEASE: Tetraamelia syndrome 1 (TETAMS1) [MIM:273395]: A form of tetraamelia, a rare disease characterized by rudimentary appendages or complete absence of all four limbs, and other anomalies such as craniofacial, nervous system, pulmonary, skeletal and urogenital defects. TETAMS1 patients manifest complete limb agenesis without defects of scapulae or clavicles. Other features include bilateral cleft lip/palate, diaphragmatic defect with bilobar right lung, renal and adrenal agenesis, pelvic hypoplasia, and urogenital defects. TETAMS1 transmission pattern is consistent with autosomal recessive inheritance. {ECO:0000269|PubMed:14872406}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.270
Intolerance Scores
- LoFtool
- 0.0728
- RVIS EVS
- -0.45
- RVIS percentile EVS
- 24
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.307
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |